Related Experiment Video
Updated: Aug 10, 2026
08:28
Experimental Metastasis Assay
Published on: August 25, 2010
Is MAGE-1 expression in metastatic malignant melanomas really helpful?
Nupoor A Gajjar1, Alistair J Cochran, Scott W Binder
1Department of Pathology, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA 90095, USA. ngajjar@mednet.ucla.edu
The American Journal of Surgical Pathology
|June 30, 2004
Summary
Melanoma antigen-encoding gene (MAGE-1) showed low sensitivity in diagnosing melanomas. S-100 protein, tyrosinase, and MART-1 are more reliable markers for melanoma diagnosis, especially for unknown primary sites.
Area of Science:
- Oncology
- Immunohistochemistry
- Dermatopathology
Background:
- Melanoma antigen-encoding gene (MAGE-1) is a proposed marker for malignant melanoma diagnosis, particularly for HMB-45 negative cases.
- The diagnostic utility and consistency of MAGE-1 require further evaluation compared to established melanoma markers.
Purpose of the Study:
- To assess the diagnostic consistency and utility of MAGE-1 in malignant melanomas.
- To compare the sensitivity of MAGE-1 with tyrosinase, MART-1, HMB-45, and S-100 protein.
Main Methods:
- Immunohistochemical analysis of 56 malignant melanoma cases.
- Evaluation of MAGE-1, tyrosinase, MART-1, HMB-45, and S-100 protein expression.
Main Results:
- MAGE-1 showed an overall positivity of 27% in the studied melanoma cohort, with lower sensitivity than previously reported.
- Tyrosinase and MART-1 were positive in 75% of cases, and S-100 protein in 93% of cases.
- MAGE-1 expression was not consistently found and did not appear to predict aggressive behavior.
Conclusions:
- MAGE-1 is less sensitive and not consistently expressed in melanomas, limiting its diagnostic utility.
- S-100 protein, tyrosinase, and MART-1 are more reliable and useful markers for diagnosing metastatic malignant melanomas, especially when the primary site is unknown.
